Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-07-13
1996-01-09
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514392, A61K 31505, A61K 31415
Patent
active
054829445
ABSTRACT:
The compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein X, m, n, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined herein are useful in the treatment of shock and other TNF.alpha.-related disorders.
REFERENCES:
patent: 4582834 (1986-04-01), Stenzel
patent: 4971959 (1990-11-01), Hawkins
Semmler et al., Immunology, 78, 520-525 (1993).
Cohan Victoria L.
Pettipher Eric R.
Ginsburg Paul H.
Goldberg Jerome D.
Holtrust Gezina
Pfizer Inc.
Richardson Peter C.
LandOfFree
Pyrimidones and imidazolinones for treatment of shock does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidones and imidazolinones for treatment of shock, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidones and imidazolinones for treatment of shock will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1303299